Table of Contents Table of Contents
Previous Page  1738 / 2894 Next Page
Information
Show Menu
Previous Page 1738 / 2894 Next Page
Page Background

348. Scheuble A, Vahanian A: Aortic insufficiency: Defi-

ning the role of pharmacotherapy. Am J Cardiovasc

Drugs 5:113–120, 2005.

349. Carabello BA: Progress in mitral and aortic regur-

gitation. Prog Cardiovasc Dis 43:457–475, 2001.

350. Otto CM: Right-sided valve disease. In Otto CM

(ed): Valvular Heart Disease, 2nd ed. Philadelphia,

WB Saunders, 2004, pp 415–437.

351. O’Rourke RA: Tricuspid valve, pulmonic valve, and

multivalvular disease.

In

Fuster V, Wayne AR,

O’Rourke RA (eds): Hurst’s the Heart, 11th ed. New

York, McGraw-Hill, 2004, pp 1707–1722.

352. Cosgrove DM III, Sabik JF: Minimally invasive

approach for aortic valve operations. Ann Thorac

Surg 62:596–597, 1996.

353. Cosgrove DM III, Sabik JF, Navia JL: Minimally

invasive valve operations. Ann Thorac Surg

65:1535–1538, 1998.

354. Mihaljevic T, Cohn LH, Unic D, et al: One thousand

minimally invasive valve operations: Early and late

results. Ann Surg 240:529–534, 2004.

355. Soltesz EG, Cohn LH: Minimally invasive valve

surgery. Cardiol Rev 15:109–115, 2007.

356. Kim BS, Soltesz EG, Cohn LH: Minimally invasive

approaches to aortic valve surgery: Brigham expe-

rience. Semin Thorac Cardiovasc Surg 18:148–153,

2006.

357. Nifong LW, ChitwoodWR, Pappas PS, et al: Robotic

mitral valve surgery: A United States multicenter

trial. J Thorac Cardiovasc Surg 129:1395–1404,

2005.

358. Brinster DR, Byrne M, Rogers CD, et al: Effective-

ness of same day percutaneous coronary interven-

tion followed by minimally invasive aortic valve

replacement for aortic stenosis and moderate coro-

nary disease (“hybrid approach”). Am J Cardiol

98:1501–1503, 2006.

359. Mohr FW, Falk V, Diegeler A, et al: Minimally inva-

sive port-access mitral valve surgery. J Thorac Car-

diovasc Surg 115:567–574, 1998.

360. Coddens J, Callebaut F, Hendrickx J, et al: Case

5—2001. Port-access cardiac surgery and aortic

dissection: The role of transesophageal echocardio-

graphy. J Cardiothorac Vasc Anesth 15:251–258,

2001.

361. Galloway AC, Shemin RJ, Glower DD, et al: First

report of the Port Access International Registry.

Ann Thorac Surg 67:51–56, 1999.

362. Reichenspurner H, Detter C, Deuse T, et al: Video

and robotic-assisted minimally invasive mitral

valve surgery: A comparison of the port-access and

transthoracic clamp techniques. Ann Thorac Surg

79:485–490, 2005.

363. Liddicoat JR, Doty JR, Stuart RS: Management of

the atherosclerotic ascending aorta with endoaortic

occlusion. Ann Thorac Surg 65:1133–1135, 1998.

364. Hunt SA, Baker DW, Chin MH, et al: ACC/AHA

guidelines for the evaluation and management of

chronic heart failure in the adult: Executive

summary. A report of the American College of Car-

diology/American Heart Association Task Force on

Practice Guidelines (Committee to Revise the 1995

Guidelines for the Evaluation and Management of

Heart Failure): Developed in collaboration with the

International Society for Heart and Lung Trans-

plantation; endorsed by the Heart Failure Society of

America. Circulation 104:2996–3007, 2001.

365. Francis GS, Goldsmith SR, Levine TB, et al: The

neurohumoral axis in congestive heart failure. Ann

Intern Med 101:370–377, 1984.

366. Levine B, Kalman J, Mayer L, et al: Elevated circu-

lating levels of tumor necrosis factor in severe

chronic heart failure. N Engl J Med 323:236–241,

1990.

367. Taylor DO, Edwards LB, Boucek MM, et al: The

Registry of the International Society for Heart and

Lung Transplantation: Twenty-first official adult

heart transplant report—2004. J Heart Lung Trans-

plant 23:796–803, 2004.

368. Gemmato CJ, Forrester MD, Myers TJ, et al: Thirty-

five years of mechanical circulatory support at the

Texas Heart Institute: An updated overview. Tex

Heart Inst J 32:168–177, 2005.

369. Frazier OH, Gregoric ID, Cohn WE: Surgical

treatment of advanced heart failure.

In

Willerson JT,

Cohn JN, Wellens HJJ, et al (eds): Cardiovascular

Medicine, 3rd ed. New York, Springer, 2007,

pp 1461–1478.

370. O’Connell JB, Bourge RC, Costanzo-Nordin MR, et

al: Cardiac transplantation: Recipient selection,

donor procurement, and medical follow-up. A sta-

tement for health professionals from the Commit-

tee on Cardiac Transplantation of the Council on

Clinical Cardiology, American Heart Association.

Circulation 86:1061–1079, 1992.

371. Natale ME, Pina IL: Evaluation of pulmonary

hypertension in heart transplant candidates. Curr

Opin Cardiol 18:136–140, 2003.

372. Kirklin JK, McGiffin DC, Pinderski LJ, et al: Selec-

tion of patients and techniques of heart transplanta-

tion. Surg Clin North Am 84:257–287, 2004, xi-xii.

373. Quinlan JJ, Murray AW, Casta A: Transfusion medi-

cine and coagulation disorders. In Kaplan JA, Reich

DL, Lake CL, et al (eds): Kaplan’s Cardiac Anesthe-

sia, 5th ed. Philadelphia, Elsevier Saunders, 2006,

pp 213–231.

374. Miller LW, Lietz K: Candidate selection for long-

term left ventricular assist device therapy for refrac-

tory heart failure. J Heart Lung Transplant

25:756–764, 2006.

375. Frazier OH, Benedict CR, Radovancevic B, et al:

Improved left ventricular function after chronic left

ventricular unloading. Ann Thorac Surg 62:675–

681, 1996.

376. Bick RJ, Poindexter BJ, Buja LM, et al: Improved

sarcoplasmic reticulum function after mechanical

left ventricular unloading. Cardiovasc Pathobiol

2:159–166, 1997.

377. Feller ED, Sorensen EN, Haddad M, et al: Clinical

outcomes are similar in pulsatile and nonpulsatile

left ventricular assist device recipients. Ann Thorac

Surg 83:1082–1088, 2007.

378. Delgado DH, Rao V, Miriuka SG, et al: Explantation

of a mechanical assist device: Assessment of myo-

cardial recovery. J Card Surg 19:47–50, 2004.

379. Maybaum S, Mancini D, Xydas S, et al: Cardiac

improvementduringmechanicalcirculatorysupport:

A prospective multicenter study of the LVAD

Working Group. Circulation 115:2497–2505, 2007.

380. XydasS,RosenRS,NgC,

etal:Mechanicalunloading

leads to echocardiographic, electrocardiographic,

neurohormonal, and histologic recovery. J Heart

Lung Transplant 25:7–15, 2006.

381. Reinlib L, Abraham W: Recovery from heart failure

with circulatory assist: A w*orking g*roup of the

National, Heart, Lung, and Blood Institute. J Card

Fail 9:459–463, 2003.

382. Hunt SA, Frazier OH: Mechanical circulatory

support and cardiac transplantation. Circulation

97:2079–2090, 1998.

383. Rose EA, Gelijns AC, Moskowitz AJ, et al: Long-term

mechanical left ventricular assistance for end-stage

heart failure. N Engl J Med 345:1435–1443, 2001.

384. Mancini D, Burkhoff D: Mechanical device–based

methods of managing and treating heart failure.

Circulation 112:438–448, 2005.

385. Nussmeier NA, Probert CB, Hirsch D, et al: Anes-

thetic management for implantation of the Jarvik

2000 left ventricular assist system. Anesth Analg

97:964–971, 2003.

386. Hourigan LA, Walters DL, Keck SA, et al: Heparin-

induced thrombocytopenia: A common complica-

tion in cardiac transplant recipients. J Heart Lung

Transplant 21:1283–1289, 2002.

387. Koster A, Huebler S, Potapov E, et al: Impact of

heparin-induced thrombocytopenia on outcome in

patients with ventricular assist device support: sin-

gle-institution experience in 358 consecutive

patients. Ann Thorac Surg 83:72–76, 2007.

388. El-Magharbel I: Ventricular assist devices and anes-

thesia. Semin Cardiothorac Vasc Anesth 9:241–249,

2005.

389. Tanaka K, Wada K, Morimoto T, et al: Hemostatic

alterations caused by ventricular assist devices for

postcardiotomy heart failure. Artif Organs 15:59–

65, 1991.

390. Dewald O, Fischlein T, Vetter HO, et al: Platelet

morphology in patients with mechanical circula-

tory support. Eur J Cardiothorac Surg 12:634–641,

1997.

391. Cooper JR Jr, Abrams J, Frazier OH, et al: Fatal pul-

monary microthrombi during surgical therapy for

end-stage heart failure: Possible association with

antifibrinolytic therapy. J Thorac Cardiovasc Surg

131:963–968, 2006.

392. Grigore AM, Joe RR, Smedira NG, et al: Assessment

in surgical procedures for congestive heart failure.

In

Savage RM, Aronson S, Thomas JD, et al (eds):

Comprehensive Textbook of Intraoperative Transe-

sophageal Echocardiography. Baltimore, Lippincott

Williams & Wilkins, 2005, pp 615–642.

393. Majd RE, Kavarana MN, Bouvette M, et al: Impro-

ved technique to diagnose a patent foramen ovale

during left ventricular assist device insertion. Ann

Thorac Surg 82:1917–1918, 2006.

394. Argenziano M, Choudhri AF, Oz MC, et al: A pros-

pective randomized trial of arginine vasopressin in

the treatment of vasodilatory shock after left ventri-

cular assist device placement. Circulation 96:II286–

II290, 1997.

395. Birks EJ, Tansley PD, Hardy J, et al: Left ventricu-

lar assist device and drug therapy for the reversal

of heart failure. N Engl J Med 355:1873–1884,

2006.

396. Renlund DG, Kfoury AG: When the failing, end-

stage heart is not end-stage. N Engl J Med 355:1922–

1925, 2006.

397. Batista RJ, Santos JL, Takeshita N, et al: Partial left

ventriculectomy to improve left ventricular function

in end-stage heart disease. J Card Surg 11:96–97,

1996.

398. Kawaguchi AT, Isomura T, Konertz W, et al: Partial

left ventriculectomy—the Third International

Registry Report 2002. Card Surg 18(Suppl 2)S33–

S42, 2003.

399. Dor V, Saab M, Coste P, et al: Left ventricular aneu-

rysm: A new surgical approach. Thorac Cardiovasc

Surg 37:11–19, 1989.

400. Kaza AK, Patel MR, Fiser SM, et al: Ventricular

reconstruction results in improved left ventricular

function and amelioration of mitral insufficiency.

Ann Surg 235:828–832, 2002.

401. Athanasuleas CL, Buckberg GD, Stanley AW, et al:

Surgical ventricular restoration in the treatment of

congestive heart failure due to post-infarction ven-

tricular dilation. J Am Coll Cardiol 44:1439–1445,

2004.

402. Mann DL, Acker MA, Jessup M, et al: Clinical eva-

luation of the CorCap Cardiac Support Device in

patients with dilated cardiomyopathy. Ann Thorac

Surg 84:1226–1235, 2007.

403. Oz MC, Konertz WF, Kleber FX, et al: Global surgi-

cal experience with the Acorn cardiac support

device. J Thorac Cardiovasc Surg 126:983–991,

2003.

404. Grossi EA, Saunders PC, Woo YJ, et al: Intraopera-

tive effects of the Coapsys annuloplasty system in a

randomized evaluation (RESTOR-MV) of functio-

nal ischemic mitral regurgitation. Ann Thorac Surg

80:1706–1711, 2005.

405. Fukamachi K, Inoue M, Doi K, et al: Device-based

left ventricular geometry change for heart failure

treatment: Developmental work and current status.

J Card Surg 18(Suppl 2)S43–S47, 2003.

406. Arabia FA: Update on the total artificial heart. J

Card Surg 16:222–227, 2001.

407. Copeland JG, Smith RG, Arabia FA, et al: Total arti-

ficial heart bridge to transplantation: A 9-year expe-

rience with 62 patients. J Heart Lung Transplant

23:823–831, 2004.

408. Morshuis M, Reiss N, Arusoglu L, et al: Implanta-

tion of CardioWest total artificial heart for irrever-

sible acute myocardial infarction shock. Heart Surg

Forum 10:E251–E256, 2007.

409. Warnes CA: The adult with congenital heart disease:

Born to be bad? J Am Coll Cardiol 46:1–8, 2005.

410. Webb GD, Williams RG: Care of the adult with con-

genital heart disease: Introduction. J Am Coll

Cardiol 37:1166, 2001.

1738

Anestesia por subespecialidades en el adulto

IV